Annual Cash & Cash Equivalents
$2.45 M
-$3.51 M-58.85%
December 1, 2023
Summary
- As of February 8, 2025, KPRX annual cash & cash equivalents is $2.45 million, with the most recent change of -$3.51 million (-58.85%) on December 1, 2023.
- During the last 3 years, KPRX annual cash & cash equivalents has risen by +$1.27 million (+107.03%).
- KPRX annual cash & cash equivalents is now -70.76% below its all-time high of $8.39 million, reached on December 31, 2015.
Performance
KPRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$5.64 M
-$938.40 K-14.27%
September 1, 2024
Summary
- As of February 8, 2025, KPRX quarterly cash and cash equivalents is $5.64 million, with the most recent change of -$938.40 thousand (-14.27%) on September 1, 2024.
- Over the past year, KPRX quarterly cash and cash equivalents has increased by +$236.50 thousand (+4.38%).
- KPRX quarterly cash and cash equivalents is now -81.98% below its all-time high of $31.28 million, reached on March 1, 2024.
Performance
KPRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KPRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.9% | +4.4% |
| 3 y3 years | +107.0% | -29.1% |
| 5 y5 years | -69.3% | -29.1% |
KPRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.8% | at low | -82.0% | +132.2% |
| 5 y | 5-year | -68.8% | +107.0% | -82.0% | +375.4% |
| alltime | all time | -70.8% | +1369.9% | -82.0% | +3275.4% |
Kiora Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.64 M(-14.3%) |
| Jun 2024 | - | $6.58 M(-79.0%) |
| Mar 2024 | - | $31.28 M(+1174.1%) |
| Dec 2023 | $2.45 M(-58.8%) | $2.45 M(-54.5%) |
| Sep 2023 | - | $5.40 M(-32.1%) |
| Jun 2023 | - | $7.95 M(+132.1%) |
| Mar 2023 | - | $3.43 M(-42.6%) |
| Dec 2022 | $5.96 M(-24.1%) | $5.96 M(+24.2%) |
| Sep 2022 | - | $4.80 M(+97.8%) |
| Jun 2022 | - | $2.43 M(-52.1%) |
| Mar 2022 | - | $5.07 M(-35.5%) |
| Dec 2021 | $7.85 M(+562.5%) | $7.85 M(-29.3%) |
| Sep 2021 | - | $11.11 M(+203.2%) |
| Jun 2021 | - | $3.66 M(-44.6%) |
| Mar 2021 | - | $6.61 M(+457.5%) |
| Dec 2020 | $1.19 M(-68.6%) | $1.19 M(-59.6%) |
| Sep 2020 | - | $2.93 M(-37.5%) |
| Jun 2020 | - | $4.69 M(-20.2%) |
| Mar 2020 | - | $5.88 M(+55.6%) |
| Dec 2019 | $3.78 M | $3.78 M(+53.9%) |
| Sep 2019 | - | $2.45 M(-45.0%) |
| Jun 2019 | - | $4.47 M(-23.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $5.86 M(-26.8%) |
| Dec 2018 | $8.00 M(+2.5%) | $8.00 M(-19.2%) |
| Sep 2018 | - | $9.90 M(-21.5%) |
| Jun 2018 | - | $12.60 M(+245.5%) |
| Mar 2018 | - | $3.65 M(-53.3%) |
| Dec 2017 | $7.81 M(+114.7%) | $7.81 M(-15.6%) |
| Sep 2017 | - | $9.24 M(-21.4%) |
| Jun 2017 | - | $11.76 M(+116.3%) |
| Mar 2017 | - | $5.44 M(+49.6%) |
| Dec 2016 | $3.64 M(-56.7%) | $3.64 M(-36.0%) |
| Sep 2016 | - | $5.68 M(-29.2%) |
| Jun 2016 | - | $8.03 M(+11.2%) |
| Mar 2016 | - | $7.21 M(-14.0%) |
| Dec 2015 | $8.39 M(+4926.4%) | $8.39 M(-15.4%) |
| Sep 2015 | - | $9.92 M(+678.6%) |
| Jun 2015 | - | $1.27 M(-44.2%) |
| Mar 2015 | - | $2.29 M(+1268.4%) |
| Dec 2014 | $167.00 K(-66.7%) | $167.00 K(-46.3%) |
| Sep 2014 | - | $311.10 K(-22.6%) |
| Jun 2014 | - | $401.80 K(-23.2%) |
| Mar 2014 | - | $523.40 K(+4.4%) |
| Dec 2013 | $501.20 K(-74.6%) | $501.20 K |
| Dec 2012 | $1.97 M | - |
FAQ
- What is Kiora Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Kiora Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Kiora Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of KPRX is $2.45 M
What is the all time high annual cash & cash equivalents for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high annual cash & cash equivalents is $8.39 M
What is Kiora Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, KPRX annual cash & cash equivalents has changed by -$3.51 M (-58.85%)
What is Kiora Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KPRX is $5.64 M
What is the all time high quarterly cash and cash equivalents for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high quarterly cash and cash equivalents is $31.28 M
What is Kiora Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, KPRX quarterly cash and cash equivalents has changed by +$236.50 K (+4.38%)